Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02483130 : Effect of N-acetylcysteine on Brain Glutamate
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Over 18 years of age

- Diagnosis of a psychotic disorder

- Have mental capacity to consent

Exclusion Criteria:

- Diagnosed drug or alcohol dependency, with the exception of nicotine

- Pregnancy, as determined through a urine pregnancy test

- Presence of any physical health abnormality which may impact on safety to participate
in the research, as determined by a study clinician on the basis of the physical
health check and the available medical information.

- Presence of electronic or metallic implants contraindicated to MRI scanning at 3
Tesla, or presence of any other contraindication to MRI

- History of asthma

- History of epilepsy or any other seizure

- Under 18 years of age

- Lacking mental capacity to consent

- Current or previous use of NAC

- Currently prescribed clozapine
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02483130      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740